[
  {
    "text": "When a new pathogen emerges,",
    "start": 6.674,
    "duration": 1.86
  },
  {
    "text": "our bodies and healthcare systems\nare left vulnerable.",
    "start": 8.534,
    "duration": 3.67
  },
  {
    "text": "In times like these,\nthere’s an urgent need for a vaccine",
    "start": 12.204,
    "duration": 3.94
  },
  {
    "text": "to create widespread immunity\nwith minimal loss of life.",
    "start": 16.144,
    "duration": 3.348
  },
  {
    "text": "So how quickly can we develop vaccines\nwhen we need them most?",
    "start": 19.492,
    "duration": 4.47
  },
  {
    "text": "Vaccine development can generally \nbe split into three phases.",
    "start": 23.962,
    "duration": 3.766
  },
  {
    "text": "In exploratory research, scientists \nexperiment with different approaches",
    "start": 27.728,
    "duration": 4.343
  },
  {
    "text": "to find safe and replicable \nvaccine designs.",
    "start": 32.071,
    "duration": 3.3
  },
  {
    "text": "Once these are vetted in the lab, \nthey enter clinical testing,",
    "start": 35.371,
    "duration": 3.84
  },
  {
    "text": "where vaccines are evaluated \nfor safety, efficacy, and side effects",
    "start": 39.211,
    "duration": 5.08
  },
  {
    "text": "across a variety of populations.",
    "start": 44.291,
    "duration": 2.825
  },
  {
    "text": "Finally, there’s manufacturing,",
    "start": 47.116,
    "duration": 2.44
  },
  {
    "text": "where vaccines are produced \nand distributed for public use.",
    "start": 49.556,
    "duration": 4.231
  },
  {
    "text": "Under regular circumstances, this process\ntakes an average of 15 to 20 years.",
    "start": 53.787,
    "duration": 5.5
  },
  {
    "text": "But during a pandemic, \nresearchers employ numerous strategies",
    "start": 59.287,
    "duration": 4.0
  },
  {
    "text": "to move through each stage \nas quickly as possible.",
    "start": 63.287,
    "duration": 2.74
  },
  {
    "text": "Exploratory research is perhaps \nthe most flexible.",
    "start": 66.027,
    "duration": 3.6
  },
  {
    "text": "The goal of this stage \nis to find a safe way",
    "start": 69.627,
    "duration": 2.99
  },
  {
    "text": "to introduce our immune system \nto the virus or bacteria.",
    "start": 72.617,
    "duration": 4.315
  },
  {
    "text": "This gives our body the information\nit needs to create antibodies",
    "start": 76.932,
    "duration": 4.46
  },
  {
    "text": "capable of fighting a real infection.",
    "start": 81.392,
    "duration": 2.67
  },
  {
    "text": "There are many ways to safely trigger\nthis immune response,",
    "start": 84.062,
    "duration": 3.7
  },
  {
    "text": "but generally, the most effective \ndesigns are also the slowest to produce.",
    "start": 87.762,
    "duration": 5.43
  },
  {
    "text": "Traditional attenuated vaccines \ncreate long lasting resilience.",
    "start": 93.192,
    "duration": 4.15
  },
  {
    "text": "But they rely on weakened viral strains",
    "start": 97.342,
    "duration": 2.57
  },
  {
    "text": "that must be cultivated in non-human\ntissue over long periods of time.",
    "start": 99.912,
    "duration": 4.641
  },
  {
    "text": "Inactivated vaccines take \na much faster approach,",
    "start": 104.553,
    "duration": 3.441
  },
  {
    "text": "directly applying heat, acid, or radiation\nto weaken the pathogen.",
    "start": 107.994,
    "duration": 5.75
  },
  {
    "text": "Sub-unit vaccines, that inject \nharmless fragments of viral proteins,",
    "start": 113.744,
    "duration": 4.472
  },
  {
    "text": "can also be created quickly.",
    "start": 118.216,
    "duration": 2.25
  },
  {
    "text": "But these faster techniques produce\nless robust resilience.",
    "start": 120.466,
    "duration": 4.535
  },
  {
    "text": "These are just three \nof many vaccine designs,",
    "start": 125.001,
    "duration": 3.12
  },
  {
    "text": "each with their own pros and cons.",
    "start": 128.121,
    "duration": 2.53
  },
  {
    "text": "No single approach is guaranteed to work,",
    "start": 130.651,
    "duration": 2.98
  },
  {
    "text": "and all of them require \ntime-consuming research.",
    "start": 133.631,
    "duration": 3.26
  },
  {
    "text": "So the best way to speed things up \nis for many labs",
    "start": 136.891,
    "duration": 3.26
  },
  {
    "text": "to work on different models \nsimultaneously.",
    "start": 140.151,
    "duration": 3.23
  },
  {
    "text": "This race-to-the-finish strategy",
    "start": 143.381,
    "duration": 2.3
  },
  {
    "text": "produced the first testable \nZika vaccine in 7 months,",
    "start": 145.681,
    "duration": 4.257
  },
  {
    "text": "and the first testable COVID-19 vaccine\nin just 42 days.",
    "start": 149.938,
    "duration": 5.15
  },
  {
    "text": "Being testable doesn’t mean \nthese vaccines will be successful.",
    "start": 155.088,
    "duration": 4.0
  },
  {
    "text": "But models that are deemed safe \nand easily replicable",
    "start": 159.088,
    "duration": 3.12
  },
  {
    "text": "can move into clinical testing while other\nlabs continue exploring alternatives.",
    "start": 162.208,
    "duration": 5.179
  },
  {
    "text": "Whether a testable vaccine is produced\nin four months or four years,",
    "start": 167.387,
    "duration": 4.509
  },
  {
    "text": "the next stage is often the longest and \nmost unpredictable stage of development.",
    "start": 171.896,
    "duration": 5.036
  },
  {
    "text": "Clinical testing consists of three phases,\neach containing multiple trials.",
    "start": 176.932,
    "duration": 5.252
  },
  {
    "text": "Phase I trials focus on the intensity \nof the triggered immune response,",
    "start": 182.184,
    "duration": 4.9
  },
  {
    "text": "and try to establish that the vaccine \nis safe and effective.",
    "start": 187.084,
    "duration": 3.84
  },
  {
    "text": "Phase II trials focus on determining \nthe right dosage and delivery schedule",
    "start": 190.924,
    "duration": 4.305
  },
  {
    "text": "across a wider population.",
    "start": 195.229,
    "duration": 2.22
  },
  {
    "text": "And Phase III trials determine safety",
    "start": 197.449,
    "duration": 2.49
  },
  {
    "text": "across the vaccine’s primary \nuse population,",
    "start": 199.939,
    "duration": 3.58
  },
  {
    "text": "while also identifying rare side effects\nand negative reactions.",
    "start": 203.519,
    "duration": 4.318
  },
  {
    "text": "Given the number of variables \nand the focus on long-term safety,",
    "start": 207.837,
    "duration": 4.15
  },
  {
    "text": "it’s incredibly difficult to speed up \nclinical testing.",
    "start": 211.987,
    "duration": 4.0
  },
  {
    "text": "In extreme circumstances, \nresearchers run multiple trials",
    "start": 215.987,
    "duration": 3.41
  },
  {
    "text": "within one phase at the same time.",
    "start": 219.397,
    "duration": 2.38
  },
  {
    "text": "But they still need to meet \nstrict safety criteria before moving on.",
    "start": 221.777,
    "duration": 4.29
  },
  {
    "text": "Occasionally, labs can expedite \nthis process by leveraging",
    "start": 226.067,
    "duration": 3.85
  },
  {
    "text": "previously approved treatments.",
    "start": 229.917,
    "duration": 2.66
  },
  {
    "text": "In 2009, researchers adapted \nthe seasonal flu vaccine to treat H1N1—",
    "start": 232.577,
    "duration": 6.186
  },
  {
    "text": "producing a widely available vaccine\nin just six months.",
    "start": 238.763,
    "duration": 5.013
  },
  {
    "text": "However, this technique only works\nwhen dealing with familiar pathogens",
    "start": 243.776,
    "duration": 4.491
  },
  {
    "text": "that have well-established \nvaccine designs.",
    "start": 248.267,
    "duration": 3.63
  },
  {
    "text": "After a successful Phase III trial, \na national regulatory authority",
    "start": 251.897,
    "duration": 4.663
  },
  {
    "text": "reviews the results and approves \nsafe vaccines for manufacturing.",
    "start": 256.56,
    "duration": 4.542
  },
  {
    "text": "Every vaccine has a unique blend \nof biological and chemical components",
    "start": 261.102,
    "duration": 4.68
  },
  {
    "text": "that require a specialized pipeline \nto produce.",
    "start": 265.782,
    "duration": 3.71
  },
  {
    "text": "To start production as soon \nas the vaccine is approved,",
    "start": 269.492,
    "duration": 2.9
  },
  {
    "text": "manufacturing plans must be designed\nin parallel to research and testing.",
    "start": 272.392,
    "duration": 5.362
  },
  {
    "text": "This requires constant coordination\nbetween labs and manufacturers,",
    "start": 277.754,
    "duration": 4.332
  },
  {
    "text": "as well as the resources to adapt\nto sudden changes in vaccine design—",
    "start": 282.086,
    "duration": 4.819
  },
  {
    "text": "even if that means scrapping\nmonths of work.",
    "start": 286.905,
    "duration": 3.7
  },
  {
    "text": "Over time, advances in exploratory\nresearch and manufacturing",
    "start": 290.605,
    "duration": 3.83
  },
  {
    "text": "should make this process faster.",
    "start": 294.435,
    "duration": 2.4
  },
  {
    "text": "Preliminary studies suggest \nthat future researchers",
    "start": 296.835,
    "duration": 2.61
  },
  {
    "text": "may be able to swap genetic material\nfrom different viruses",
    "start": 299.445,
    "duration": 3.89
  },
  {
    "text": "into the same vaccine design.",
    "start": 303.335,
    "duration": 2.77
  },
  {
    "text": "These DNA and mRNA based vaccines\ncould dramatically expedite",
    "start": 306.105,
    "duration": 5.054
  },
  {
    "text": "all three stages of vaccine production.",
    "start": 311.159,
    "duration": 2.66
  },
  {
    "text": "But until such breakthroughs arrive,",
    "start": 313.819,
    "duration": 2.13
  },
  {
    "text": "our best strategy is for labs \naround the world to cooperate",
    "start": 315.949,
    "duration": 3.994
  },
  {
    "text": "and work in parallel \non different approaches.",
    "start": 319.943,
    "duration": 2.8
  },
  {
    "text": "By sharing knowledge and resources,",
    "start": 322.743,
    "duration": 2.24
  },
  {
    "text": "scientists can divide and conquer \nany pathogen.",
    "start": 324.983,
    "duration": 3.802
  }
]